NCT02676778
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Eisai Trial Site #1 Nagoya, Aichi-ken, Japan
- Eisai Trial Site #2 Nagoya, Aichi-ken, Japan
- Eisai Trial Site #1 Kashiwa, Chiba, Japan
- Eisai Trial Site #1 Ōta, Gunma, Japan